Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin

Table 1

Effect of 1% cholesterol diet and Trihoney on animal’s food intake.

Groups	Food intake (g), week 0	Food intake (g), week 12
C	112.86 ± 15.69^a	106.86 ± 39.04^a
C + H	118.38 ± 33.34^a	89.50 ± 55.68^a
HCD	100.87 ± 37.21^a	74.50 ± 30.92^a
HCD + H1	81.87 ± 35.93^a	80.00 ± 42.50^a
HCD + H2	99.50 ± 45.11^a	80.25 ± 31.59^a
HCD + At	85.25 ± 36.73^a	80.28 ± 26.69^a

Values are mean ± standard deviation (SD) of the mean. The results of all experiment groups were analysed using one-way analysis of variance (ANOVA), followed by the Tukey HSD post hoc test. Mean difference is considered significant at . ^aValues not sharing a common superscript letter within the same column differ significantly at . C = control and C + H = control group received a honey dose of 0.6 g/kg. HCD = high cholesterol diet; HCD + H₁ and HCD + H₂ = atherogenic groups received a honey dose of 0.3 and 0.6 g/kg, respectively; HCD + At = atherogenic group received atorvastatin dose of 2 mg/kg.